Investigating gut microbiota–blood and urine metabolite correlations in early sepsis-induced acute kidney injury: insights from targeted KEGG analyses
Open Access
- 3 June 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1375874
Abstract
Background: The interplay between gut microbiota and metabolites in the early stages of sepsis-induced acute kidney injury (SA-AKI) is not yet clearly understood. This study explores the characteristics and interactions of gut microbiota, and blood and urinary metabolites in patients with SA-AKI.Methods: Utilizing a prospective observational approach, we conducted comparative analyses of gut microbiota and metabolites via metabolomics and metagenomics in individuals diagnosed with SA-AKI compared to those without AKI (NCT06197828). Pearson correlations were used to identify associations between microbiota, metabolites, and clinical indicators. The Comprehensive Antibiotic Resistance Database was employed to detect antibiotic resistance genes (ARGs), while Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways informed on metabolic processes and microbial resistance patterns.Results: Our study included analysis of four patients with SA-AKI and five without AKI. Significant disparities in bacterial composition were observed, illustrated by diversity indices (Shannon index: 2.0 ± 0.4 vs. 1.4 ± 0.6, P = 0.230; Simpson index: 0.8 ± 0.1 vs. 0.6 ± 0.2, P = 0.494) between the SA-AKI group and the non-AKI group. N6, N6, N6-Trimethyl-L-lysine was detected in both blood and urine metabolites, and also showed significant correlations with specific gut microbiota (Campylobacter hominis and Bacteroides caccae, R > 0, P < 0.05). Both blood and urine metabolites were enriched in the lysine degradation pathway. We also identified the citrate cycle (TCA cycle) as a KEGG pathway enriched in sets of differentially expressed ARGs in the gut microbiota, which exhibits an association with lysine degradation.Conclusions: Significant differences in gut microbiota and metabolites were observed between the SA-AKI and non-AKI groups, uncovering potential biomarkers and metabolic changes linked to SA-AKI. The lysine degradation pathway may serve as a crucial link connecting gut microbiota and metabolites.Keywords
This publication has 55 references indexed in Scilit:
- Diagnosis of Clostridium difficile infection using an UPLC–MS based metabolomics methodMetabolomics, 2018
- 13-Docosenamide release by bacteria in response to glucose during growth—fluorescein quenching and clinical applicationApplied Microbiology and Biotechnology, 2018
- Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma MetabolitesCell Reports, 2018
- Layered defense: how mucus and tight junctions seal the intestinal barrierJournal of Molecular Medicine, 2017
- Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot studyIntensive Care Medicine, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Analysis of human urine reveals metabolic changes related to the development of acute kidney injury following cardiac surgeryMetabolomics, 2012
- Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemiaIntensive Care Medicine, 2010
- An Invitation to the Marriage of Metagenomics and MetabolomicsCell, 2008
- Isolation of fatty acid amide as an angiogenic principle from bovine mesenteryBiochemical and Biophysical Research Communications, 1990